| Bioactivity | Talviraline is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is primarily used to inhibit the replication of human immunodeficiency virus type 1 (HIV-1). Talviraline inhibits the viral replication process by binding to a specific site of HIV-1 reverse transcriptase (RT). Talviraline can be used to study the potential countermeasures and safety of HIV-1 infection[1]. |
| CAS | 163451-80-7 |
| Formula | C15H20N2O3S2 |
| Molar Mass | 340.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kleim J P, et al. Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication[J]. Antimicrobial agents and chemotherapy, 1995, 39(10): 2253-2257. |
Talviraline
CAS: 163451-80-7 F: C15H20N2O3S2 W: 340.46
Talviraline is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is primarily used to inhibit the replicatio
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.